Trump’s Aggressive Advocacy of Malaria Drug for Treating Coronavirus Divides Medical Community
▻https://www.nytimes.com/2020/04/06/us/politics/coronavirus-trump-malaria-drug.html
If hydroxychloroquine becomes an accepted treatment, several pharmaceutical companies stand to profit, including shareholders and senior executives with connections to the president. Mr. Trump himself has a small personal financial interest in Sanofi, the French drugmaker that makes Plaquenil, the brand-name version of hydroxychloroquine.